Skip to content
AnalystLens

LDOS · Leidos Holdings

344 filings

LDOS SEC Filings

Leidos Holdings - 344 total filings

Filing record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’18Aug ’18
  2. Leadership change8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Feb ’23Feb ’23
  4. Material agreement8-K · Feb ’25Feb ’25
Showing 1–50 of 344 filings
8-K

Leidos Holdings 8-K Report, Financial Results (Nov 3, 2026)

Leidos Holdings, Inc. (NYSE: LDOS) reported results for its third fiscal quarter ended October 2, 2026, in a press release furnished as Exhibit 99.1 to this Item 2.02 Form 8-K. Revenues were $4.63 billion, up 4% year-over-year, driven by demand for defense tech products, air traffic management and intelligence mission support, plus the acquisition of ENTRUST Solutions, partly offset by declines in some managed health and federal civilian IT programs. GAAP net income was $413 million, or $3.28 per diluted share, versus $369 million and $2.82 a year earlier. Non-GAAP diluted EPS was $3.62, up 19% year-over-year, and adjusted EBITDA was $644 million at a 13.9% margin. Net bookings were $5.5 billion for a 1.2 book-to-bill ratio, and backlog reached $49.6 billion, of which $11.1 billion was funded. Cash flow from operations was $523 million and non-GAAP free cash flow was $476 million for the quarter. The company returned $556 million to shareholders, including $504 million of share repurchases and $52 million of dividends. As of October 2, 2026, Leidos had $630 million in cash and cash equivalents and $6.0 billion of debt. The Board declared a quarterly dividend of $0.45 per share, payable December 31, 2026. Following the October 5, 2026 closing of the Contribution and Equity Purchase Agreement with Altaris, which contributed the Security Enterprise Solutions and Industrial Automation (SES) businesses to a newly formed joint venture, Leidos lowered its fiscal 2026 revenue guidance to $18.00 to $18.20 billion from $18.20 to $18.40 billion. It raised non-GAAP diluted EPS guidance to $12.50 to $12.70 from $12.20 to $12.50, and kept adjusted EBITDA margin at mid-13%. Operating cash flow guidance was about $1.90 billion, up from about $1.85 billion.

Nov 3, 2026
10-Q

Leidos Holdings Quarterly Report for Q3 Ended Oct 2, 2026

Leidos Holdings, Inc. reported third-quarter fiscal 2026 revenues of $4.63 billion, up 3.6% from $4.47 billion a year earlier, and operating income of $553 million, up 3.4%. Net income attributable to common stockholders was $410 million, and diluted EPS was $3.28 versus $2.82. For the nine months, revenues rose 4.8% to $13.59 billion, but operating income fell 3.7% to $1.58 billion, and diluted EPS was $8.67 versus $8.62. Results were mixed by segment: Homeland grew sharply, helped by the Entrust acquisition, while Health revenue fell 11.7% in the quarter, with operating income down 25.9%, due to reduced managed health services volumes and lower incentive fees. The balance sheet changed meaningfully during the period. Leidos completed the approximately $2.4 billion cash acquisition of Entrust on March 27, 2026, funded partly by $1.4 billion of new senior notes. Total debt rose to $6.0 billion from $4.6 billion at fiscal year-end, and cash fell to $630 million. Goodwill increased to $7.7 billion. Nine-month operating cash flow improved to $1.62 billion from $1.26 billion, and the company returned capital through $766 million of open-market buybacks and dividends of $0.43 per share each quarter. After quarter-end, on October 5, 2026, Leidos closed the contribution of its Security Enterprise Solutions and Industrial Automation businesses into a joint venture with Altaris, retaining a 41.5% non-controlling interest. The company expects a non-operating gain of approximately $100 million in the fourth quarter, and it expects fourth-quarter revenues to be lower as a result. Total net bookings were $13.7 billion for the nine months, and total backlog stood at $49.6 billion. The filing also discloses an open Department of Justice Antitrust Division grand jury investigation, for which the company says it cannot currently estimate any potential liability.

Nov 3, 2026
8-K

Leidos Holdings 8-K Report, Material Agreement (Oct 5, 2026)

On October 5, 2026, Leidos completed a previously announced transaction in which its Security Enterprise Solutions and Industrial Automation businesses (the SES/IA Business) were combined with Analogic Corporation, a portfolio company of Altaris, to form a new joint venture, Nickel JV Ultimate Parent, LLC (the JV). Leidos, Inc. contributed the SES/IA Business in exchange for 41.5% of the JV's equity, while certain Altaris entities (the AHP Investor) contributed a portion of Analogic's parent equity in exchange for 58.5%. The remaining Analogic equity was sold to the JV for cash raised through new debt financing (the Debt Financing). Under the amended and restated LLC agreement, the Altaris entities will appoint a majority of the JV's board and hold majority voting power, while Leidos Inc. will initially designate a minority of board seats and hold minority investor protective rights. No member is obligated to make further capital contributions after closing, and distributions will be made at the Board's discretion and at least once annually. The agreement also grants the Altaris investor drag-along rights, grants Leidos tag-along rights, and, after the seven-year anniversary of closing, gives Leidos certain liquidity demand exit rights, subject to timing and procedural limitations. The new company will operate under the Analogic brand. Leidos said it will retain a significant minority ownership stake and that the transaction sharpens its focus on growth engines under its NorthStar 2030 strategy. Leidos will continue its aviation-ecosystem work, including airport and air traffic system modernization. The press release is furnished under Item 7.01 and is not deemed filed for Section 18 purposes.

Oct 5, 2026
8-K

Leidos Holdings 8-K Report, Executive Changes (Oct 1, 2026)

Leidos Holdings, Inc. filed a Current Report on Form 8-K dated October 1, 2026, to report that its Board of Directors increased the size of the Board to 11 members and elected Jeffery S. McElfresh as a Director, effective October 1, 2026. The Board determined Mr. McElfresh is independent under New York Stock Exchange requirements. He will receive standard non-employee director compensation as described in the Company's proxy statement filed on March 19, 2026, and will serve on the Corporate Governance and Ethics Committee and the Technology and Information Security Committee. The filing states there are no arrangements or understandings between Mr. McElfresh and any other person under which he was selected as a director, and no related-party transactions under Item 404(a) of Regulation S-K involving him. The accompanying press release (Exhibit 99.1) identifies him as AT&T's chief operating officer, overseeing AT&T's $250 billion nationwide advanced connectivity infrastructure transformation, and notes his prior oversight of AT&T's cybersecurity, data management, and labs. For investors, this is a governance event rather than a financial one. The filing contains no financial results or guidance. The press release describes the appointment as supporting Leidos' NorthStar 2030 growth strategy and its work in critical technologies for national security and other customers, and it states the company reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.

Oct 1, 2026
8-K

Leidos Holdings 8-K Report, Financial Results (Aug 4, 2026)

Leidos Holdings, Inc. reported results for its second fiscal quarter ended July 3, 2026, in a press release furnished as Exhibit 99.1 to this Form 8-K. Revenues were $4.56 billion, up 7% year-over-year (4% organically), and net income was $356 million, or $2.81 per diluted share, versus $393 million and $3.01 a year earlier. Net income reflected $29 million of costs tied to the Entrust Solutions Group acquisition, the pending joint venture with Analogic Corporation, and restructuring associated with the NorthStar 2030 re-alignment. Adjusted EBITDA was $631 million with a 13.8% margin (15.2% a year ago), and non-GAAP diluted EPS rose 2% to $3.26. Cash generation was strong: net cash provided by operating activities was $793 million and non-GAAP free cash flow was $761 million for the quarter. Net bookings were $4.9 billion with a book-to-bill ratio of 1.1, bringing total backlog to $48.7 billion, of which $10.2 billion was funded. The company repaid $300 million of commercial paper and returned $127 million to shareholders, and it ended the quarter with $748 million of cash and $6.0 billion of debt. Management raised fiscal 2026 guidance: revenues of $18.20 to $18.40 billion (previously $18.00 to $18.40 billion), non-GAAP diluted EPS of $12.20 to $12.50 (previously $12.10 to $12.50), operating cash flow of approximately $1.85 billion (previously approximately $1.80 billion), and an unchanged adjusted EBITDA margin in the mid-13% range.

Aug 4, 2026
10-Q

Leidos Holdings Quarterly Report for Q2 Ended Jul 3, 2026

Leidos Holdings, Inc. reported second-quarter fiscal 2026 revenues of $4,558 million, up 7.2% from $4,253 million a year earlier, with the increase attributed to program wins and the Entrust acquisition. Operating income fell to $514 million from $571 million, and operating margin declined to 11.3% from 13.4%. Net income attributable to Leidos common stockholders was $354 million, or $2.81 per diluted share, compared with $391 million, or $3.01 per diluted share, in the prior-year quarter. For the six months, revenues were $8,958 million (up 5.4%) and diluted EPS was $5.37, versus $5.80. The company attributes the margin pressure partly to higher acquisition, integration and restructuring costs, a $23 million pension settlement loss, and higher interest expense. The balance sheet changed materially. On March 27, 2026, Leidos completed the acquisition of Entrust for a purchase price of $2.4 billion in cash, funded in part by $1.4 billion of new senior notes. Total debt rose to $6.0 billion from $4.6 billion at fiscal year-end, and cash and cash equivalents were $748 million. Goodwill increased to $7,663 million. Net cash provided by operating activities was $1,094 million for the six months, compared with $544 million a year earlier, driven mainly by working capital changes. Leidos also agreed to divest its Security Enterprise Solutions and Industrial Automation businesses into a joint venture with Altaris, retaining a 41.5% non-controlling interest. The company reported total backlog of $48.7 billion and net bookings of $4.9 billion for the quarter, and it authorized a new share repurchase program of up to 20 million shares in July 2026. The filing also flags risks. Roughly 83% of second-quarter revenues came from U.S. government contracts. The company notes that failure to pass appropriations or a continuing resolution by September 30, 2026 would result in a full or partial federal government shutdown. Leidos is cooperating with a Department of Justice Antitrust Division criminal investigation tied to a 2022 grand jury subpoena and cannot yet estimate any potential liabilities.

Aug 4, 2026
8-K

Leidos Holdings 8-K Report, Executive Changes (May 6, 2026)

Leidos Holdings, Inc. reported that at its Annual Meeting of Stockholders held on May 1, 2026, stockholders approved the Company's 2026 Omnibus Incentive Plan and 2026 Employee Stock Purchase Plan (ESPP). The Board had previously approved both plans subject to stockholder approval. The filing incorporates the plans' material terms from the Company's Proxy Statement filed March 19, 2026, and states that copies of the plans were filed with a Form S-8 registration statement on May 1, 2026. All ten board nominees were elected to one-year terms. Robert S. Shapard received the most votes against his election, at 11,532,656, while the other nominees received fewer against votes. Stockholders also approved, on a non-binding advisory basis, the compensation of the named executive officers, with 88,904,849 votes for and 4,449,801 against. They ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending January 1, 2027, with 97,307,718 votes for and 7,074,729 against. The 2026 Omnibus Incentive Plan received 90,310,588 votes for and 3,322,318 against, and the 2026 ESPP received 93,480,480 votes for and 378,610 against. Both plans had 10,494,880 broker non-votes. For investors, the filing shows that the new equity compensation plans were approved and that the board slate, executive pay vote, and auditor ratification all passed.

May 6, 2026
8-K

Leidos Holdings 8-K Report, Financial Results (May 5, 2026)

Leidos Holdings, Inc. (NYSE: LDOS) reported first-quarter fiscal 2026 results for the quarter ended April 3, 2026, with revenues of $4.40 billion, up 4% year-over-year (3% organically), and net income of $335 million, or $2.56 per diluted share, down 8% from the prior year. Non-GAAP diluted EPS rose 5% to $3.13 and adjusted EBITDA was $614 million, with an adjusted EBITDA margin of 14.0% compared with 14.2% a year earlier. Net income and EPS absorbed $39 million of costs tied to the Entrust Solutions Group acquisition and the pending joint venture combining Leidos' Security Enterprise Solutions and Industrial Automation businesses with Analogic Corporation. Cash flow from operations was $301 million and non-GAAP free cash flow was $270 million. The Entrust acquisition, the primary investment in the quarter, consumed $2.34 billion of cash, financed largely by $1.4 billion of senior notes and $300 million of commercial paper. Total debt stood at $6.3 billion and cash and equivalents at $457 million at quarter end. Net bookings were $3.3 billion, giving a book-to-bill of 0.8 for the quarter, and total backlog reached $48.4 billion, of which $9.6 billion was funded. Leidos raised its fiscal 2026 guidance, with revenues now expected at $18.00 to $18.40 billion (previously $17.50 to $17.90 billion), non-GAAP diluted EPS at $12.10 to $12.50 (previously $12.05 to $12.45), and operating cash flow of approximately $1.80 billion (previously approximately $1.75 billion). The adjusted EBITDA margin outlook is unchanged at a mid-13% level. The company also declared a quarterly dividend of $0.43 per share, payable June 30, 2026.

May 5, 2026
10-Q

Leidos Holdings Quarterly Report for Q1 Ended Apr 3, 2026

Leidos Holdings, Inc. reported revenues of $4.40 billion for the three months ended April 3, 2026, up from $4.25 billion in the prior-year quarter, while operating income was $508 million compared with $530 million. Net income attributable to Leidos common stockholders was $328 million, or $2.56 per diluted share, versus $363 million, or $2.77 per diluted share, a year earlier. The quarter was shaped by the acquisition of Entrust for $2.4 billion in cash on March 27, 2026, which drove a $2.34 billion net cash outflow in investing activities, and by a $23 million pension settlement loss from the buy-out of the UK defined benefit plan. Total backlog rose to $48.37 billion from $46.30 billion, and net bookings were an estimated $3.3 billion compared with $2.1 billion a year earlier. Debt rose to $6.3 billion from $4.6 billion, reflecting $600 million and $800 million senior notes issued in March 2026, along with $300 million of commercial paper outstanding. Cash and cash equivalents fell to $457 million from $1.108 billion at January 2, 2026. Operating cash flow improved to $301 million from $58 million, mainly due to favorable working capital changes. The company also repurchased $200 million of open market shares during the quarter and paid $55 million in dividends. Looking ahead, Leidos agreed on April 14, 2026, to contribute its Security Enterprise Solutions and Industrial Automation businesses to a new joint venture with Analogic Corporation, in exchange for a 41.5% equity interest, with closing expected in the second half of fiscal 2026. The Entrust purchase price allocation is preliminary, and the company has not finalized fair values for substantially all acquired assets and liabilities. The company also disclosed an ongoing U.S. Department of Justice Antitrust Division criminal investigation, for which it says it cannot currently estimate any potential liability.

May 5, 2026
8-K

Leidos Holdings 8-K Report, Material Agreement (Apr 15, 2026)

Leidos Holdings, Inc. (NYSE: LDOS) disclosed that on April 14, 2026, its wholly-owned subsidiary Leidos, Inc. entered into a Contribution and Equity Purchase Agreement with certain affiliates of Altaris, LLC to form a new joint venture. The joint venture will combine Leidos' Security Enterprise Solutions and Industrial Automation businesses (together, the SES/IA Business) with Analogic Corporation, a portfolio company of Altaris. Under the agreement, Leidos, Inc. will contribute the SES/IA Business in exchange for 41.5% of the joint venture's equity, while certain Altaris entities will contribute a portion of Analogic's parent and sell the remainder to the joint venture for cash funded by new debt financing, in exchange for 58.5% of the equity. The transaction is expected to close in the second half of 2026. Closing is subject to customary conditions, including expiration or termination of the Hart-Scott-Rodino waiting period, receipt of other required regulatory consents, completion of a pre-closing restructuring, and the joint venture obtaining the debt financing. Either party may terminate under specified circumstances, including if the transactions are not consummated by the six-month anniversary of the agreement, subject to an automatic three-month extension. Leidos, Inc. has also bound a representations and warranties insurance policy, and the agreement includes non-competition and non-solicitation covenants applicable to Leidos, Inc. and its subsidiaries. According to the accompanying press release, Leidos will contribute approximately 1,500 employees representing $625 million in projected 2026 revenue to the joint venture, which will operate under the Analogic brand with Leidos retaining significant minority ownership. The press release states the transaction is intended to strengthen U.S. security detection capabilities and support the NorthStar 2030 strategy's core growth areas.

Apr 15, 2026
8-K

Leidos Holdings 8-K Report, Acquisition Completed (Mar 30, 2026)

On March 27, 2026, Leidos, Inc., a wholly-owned subsidiary of Leidos Holdings, Inc., completed its acquisition of KENE Parent, Inc. (ENTRUST Solutions Group) from KENE Holdings, L.P. under a Stock Purchase Agreement dated January 23, 2026. The purchase price was $2.4 billion in cash, subject to customary adjustments for Entrust's cash, debt, transaction expenses and net working capital. The transaction was announced in a press release dated March 30, 2026 (Exhibit 99.1). According to the press release, the acquisition creates a scaled, end-to-end energy infrastructure organization focused on grid modernization. The company states that adding ENTRUST effectively doubles Leidos' presence in the energy infrastructure market, bringing more than 3,100 professionals with expertise in electric grid engineering and natural gas infrastructure, and broadens its base of utility customers. The release ties the deal to the energy growth pillar of the company's NorthStar 2030 strategy. The filing notes that Leidos reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026, and has 47,000 global employees. The press release's forward-looking statements flag risks including the company's ability to complete and integrate the transaction and to complete the intended permanent financing.

Mar 30, 2026
8-K

Leidos Holdings 8-K Report, Material Agreement (Mar 3, 2026)

Leidos, Inc., a direct wholly-owned subsidiary of Leidos Holdings, Inc., issued and sold $600 million of 4.100% senior notes due 2029 and $800 million of 5.000% senior notes due 2036 on March 2, 2026, under its automatic shelf registration statement on Form S-3. The senior unsecured notes are guaranteed by Leidos Holdings, and the filing states estimated net proceeds of approximately $1,387 million after underwriting discounts and estimated offering expenses. The Issuer intends to use the proceeds to fund a portion of the consideration for its proposed acquisition of KENE Parent, Inc. ("ENTRUST") under a Stock Purchase Agreement dated January 23, 2026. The note sale is not conditioned on completion of the ENTRUST acquisition. The notes carry semi-annual interest payable on March 15 and September 15, beginning September 15, 2026, with maturities on March 15, 2029 and March 15, 2036. Holders are protected by a change of control repurchase offer at 101% of principal. If the ENTRUST acquisition is not consummated by the later of August 14, 2026 (the End Date, subject to extension) or five business days after any extended date, or if the Issuer notifies the Trustee it will not pursue the deal, the notes must be redeemed in whole at 101% of principal plus accrued interest. Investors should weigh this special mandatory redemption feature, which effectively makes the notes contingent on the ENTRUST deal closing. The filing also incorporates the notes issuance into Item 2.03 as a direct financial obligation. Exhibits include the underwriting agreement dated February 19, 2026, the officers' certificate dated March 2, 2026, the global note forms, and a legal opinion from Davis Polk & Wardwell LLP.

Mar 3, 2026
8-K

Leidos Holdings 8-K Report, Material Agreement (Feb 17, 2026)

Leidos Holdings, Inc. ("Leidos") disclosed that on February 12, 2026 (the "Restatement Effective Date"), it and its subsidiaries entered into an Amendment and Restatement Agreement that amended and restated the Credit Agreement dated as of March 10, 2023. Leidos, Inc., a wholly-owned subsidiary, is the borrower, and certain other wholly-owned domestic subsidiaries are guarantors. Citibank, N.A. is administrative agent. The principal change is to the revolving credit facility, which the filing says was increased from $1.0 billion to $1.5 billion, with its maturity extended to five years after the Restatement Effective Date. The unused commitment fee is reduced to a range of 0.08% to 0.20% per annum on a ratings-based grid, from 0.09% to 0.25%, and a 0.10% per annum credit spread adjustment on revolver borrowings has been removed. No borrowings were outstanding under the revolver as of the Restatement Effective Date, and it remains available for working capital and general corporate purposes. The filing states that the term loan facility's maturity date, principal amount and pricing were not modified. It also says the representations, warranties and covenants are substantially similar to the Existing Credit Agreement, subject to certain modifications. The full agreement is filed as Exhibit 10.1.

Feb 17, 2026
10-K

Leidos Holdings Annual Report, Year Ended Jan 2, 2026

Leidos Holdings, Inc. ("Leidos") reported fiscal 2025 (ended January 2, 2026) revenues of $17,174 million, up 3% from $16,662 million in fiscal 2024, with operating income of $2,109 million (operating margin of 12.3%, versus 11.0% in fiscal 2024) and net income attributable to common stockholders of $1,448 million, compared with $1,254 million a year earlier. Diluted EPS was $11.14, versus $9.22. The company states that 87% of revenues came from U.S. government contracts, and approximately 49% came from contracts with the DoW and U.S. Intelligence Community. Total backlog was $49,032 million, including $9,685 million funded, versus $48,390 million a year earlier. Cash flow from operations was $1,750 million, up from $1,435 million, which the company attributes mainly to tax benefits from the One Big Beautiful Bill Act and favorable working capital changes. The company ended the year with $1,108 million of cash and cash equivalents and $4.6 billion of debt. Leidos repurchased $944 million of stock in financing activities and paid $211 million in dividends, with dividends declared at $1.63 per share for the year. On January 23, 2026, the company agreed to acquire Entrust (KENE Parent, Inc.) for $2.4 billion in cash, funded in part by a $1.4 billion 364-day bridge facility, and on February 12, 2026 it raised its revolving credit facility to $1.5 billion from $1.0 billion. The filing also flags several risks, including U.S. government budget uncertainty and continuing resolutions, bid protests and competitive pricing pressure, contract termination rights, an open DOJ Antitrust Division grand jury subpoena related to three 2021 and 2022 procurements, and the Executive Order "Prioritizing the Warfighter in Defense Contracting," which may restrict buybacks, dividends and executive incentive pay on future contracts. The company also plans to realign into four new reportable segments starting in fiscal 2026.

Feb 17, 2026
8-K

Leidos Holdings 8-K Report, Financial Results (Feb 17, 2026)

Leidos Holdings, Inc. reported fourth-quarter and fiscal year 2025 results (fiscal year ended January 2, 2026). Fourth-quarter revenues were $4.21 billion, down 4% year-over-year, reflecting an extra work week in the prior-year quarter and a six-week government shutdown in the fourth quarter of 2025. Fiscal year revenues were $17.17 billion, up 3%. Diluted EPS was $2.53 for the quarter (up 19%) and $11.14 for the year (up 21%). Non-GAAP diluted EPS was $2.76 for the quarter (up 16%) and $11.99 for the year (up 17%). Net bookings were $5.6 billion for the quarter (book-to-bill 1.3) and $17.5 billion for the year (book-to-bill 1.0), with backlog of $49.0 billion at year-end, of which $9.7 billion was funded. Operating cash flow was $495 million for the quarter and $1.75 billion for the year, with free cash flow of $1.63 billion for the year. Leidos guided fiscal 2026 revenues of $17.5 to $17.9 billion, an adjusted EBITDA margin in the mid-13% range, non-GAAP diluted EPS of $12.05 to $12.45, and operating cash flow of approximately $1.75 billion. The company also announced an agreement to acquire power design firm Entrust for $2.4 billion, expected to close in the first half of fiscal 2026. Separately, effective January 3, 2026, Leidos moved to a four-segment structure (Intelligence & Digital, Health, Homeland, and Defense), with recast historical figures furnished in Exhibit 99.2. The filing also highlights a $2.2 billion Air Force ABADS-MD award and a board-declared quarterly dividend of $0.43 per share payable March 31, 2026. Investors will want to weigh the strong earnings and cash generation against the revenue decline in the quarter, the pending Entrust acquisition, and the new segment reporting basis.

Feb 17, 2026
8-K

Leidos Holdings 8-K Report, Material Agreement (Jan 26, 2026)

Leidos, Inc., a wholly-owned subsidiary of Leidos Holdings, Inc., entered into a Stock Purchase Agreement on January 23, 2026 with KENE Holdings, L.P. (Seller) and KENE Parent, Inc. (Entrust) to acquire all outstanding shares of Entrust for a base purchase price of $2,400,000,000 in cash, subject to customary adjustments for Entrust's cash, debt, transaction expenses and net working capital. The transaction is expected to close in the second quarter of 2026, subject to conditions including expiration or termination of the Hart-Scott-Rodino waiting period, the absence of prohibiting laws or orders, and the absence of a material adverse effect on Entrust. Either party may terminate if the transaction is not consummated by August 14, 2026, among other specified grounds. To finance the deal, Leidos and the Purchaser entered into a commitment letter with Citigroup Global Markets Inc. for a customary senior unsecured 364-day bridge credit facility of $1.4 billion. The filing states the consummation of the transaction is not subject to any financing condition. If drawn, the bridge would bear interest at Term SOFR plus an applicable margin initially ranging from 1.00% to 1.50%, currently 1.25% for SOFR-denominated borrowings, and Leidos may instead pursue alternative permanent financing. The company's January 26, 2026 press release and investor presentation describe Entrust as a power and energy engineering firm with 3,100+ professionals across 40+ North American locations, and state that the transaction is expected to be immediately accretive to revenue growth and adjusted EBITDA margin and accretive to non-GAAP diluted EPS in 2027. The investor presentation states the funding plan as $1.4 billion in new debt, $500 million in cash and $500 million in commercial paper, with pro forma gross leverage at close of 2.6x. Entrust's 2026E revenue is shown as approximately $650 million with an adjusted EBITDA margin in the low 20% range, and the presentation lists pro forma 2026E revenue of $1.3 billion for the combined energy business.

Jan 26, 2026
10-Q

Leidos Holdings Quarterly Report for Q3 Ended Oct 3, 2025

Leidos Holdings, Inc. reported third-quarter fiscal 2025 results for the three months ended October 3, 2025, with revenues of $4,469 million, up from $4,190 million a year earlier, and operating income of $535 million versus $516 million. Net income attributable to Leidos common stockholders was $367 million, or $2.82 diluted EPS, compared with $364 million and $2.68 a year earlier. For the nine months, revenues were $12,967 million and operating income was $1,636 million, with diluted EPS of $8.62. The filing notes that the company's bookings were an estimated $5.9 billion for the quarter, with total backlog of $47,656 million and remaining performance obligations of $17 billion. Approximately 87% of revenues came from U.S. government contracts in both periods. Cash flow and balance sheet activity were shaped by capital allocation and debt management. Net cash provided by operating activities was $1,255 million for the nine months, helped by tax benefits from the One Big Beautiful Bill Act (OBBBA). The company acquired Kudu Dynamics for $293 million net of cash acquired, repaid $1,014 million of borrowings including a $450 million term loan prepayment in the quarter, and repurchased $639 million of stock for the nine months. Cash and cash equivalents stood at $974 million, total debt was $4.7 billion, and the company stated it was in compliance with all financial covenants. The filing also highlights several risks and open items. The U.S. federal government shut down on October 1, 2025, which the company says may reduce or delay work and payments. Active Defense Contract Audit Agency audits remain open for fiscal 2023 and later, and the company disclosed a Federal Grand Jury subpoena from a Department of Justice Antitrust Division investigation, stating it is not possible at this time to determine whether it will incur any fines or penalties. The company also reported an SEC matter it has self-reported, with timing and outcome not anticipated. Management stated that the legal matters are not expected to have a material adverse effect on financial position, results of operations or cash flows.

Nov 4, 2025
8-K

Leidos Holdings 8-K Report, Financial Results (Nov 4, 2025)

Leidos Holdings, Inc. (NYSE: LDOS) reported results for the third fiscal quarter ended October 3, 2025, in a press release furnished as Exhibit 99.1 to this Form 8-K. Revenues were $4,469 million, up 7% year-over-year (6% organic), and net income was $369 million, or $2.82 per diluted share. Adjusted EBITDA was $616 million with a 13.8% margin, down from 14.2% a year earlier, and non-GAAP diluted EPS was $3.05, up 4% year-over-year. Operating cash flow was $711 million and non-GAAP free cash flow was $680 million. Net bookings were $5.9 billion for a book-to-bill ratio of 1.3, and total backlog reached $47.7 billion, up 5% year-over-year, of which $9.1 billion was funded. Notable awards included a $2.2 billion, seven-year classified mission support contract in the intelligence community and a $760 million NASA Human Health and Performance IDIQ subcontract. Management cited the U.S. government shutdown as a factor but raised its fiscal 2025 adjusted EBITDA margin guidance to high 13% (from mid 13%) and non-GAAP diluted EPS guidance to $11.45–$11.75 (from $11.15–$11.45), while holding revenue guidance at $17.00–$17.25 billion and operating cash flow guidance at approximately $1.65 billion. The company ended the quarter with $974 million in cash and cash equivalents and $4.7 billion of debt, after $450 million in term loan principal payments and $153 million returned to shareholders. On October 31, 2025, the board declared a quarterly dividend of $0.43 per share, payable December 31, 2025.

Nov 4, 2025
8-K

Leidos Holdings 8-K Report, Financial Results (Aug 5, 2025)

Leidos Holdings, Inc. (NYSE: LDOS) reported results for its second fiscal quarter ended July 4, 2025, with revenues of $4.25 billion, up 3% from the prior-year quarter, and net income of $393 million, or $3.01 per diluted share. Adjusted EBITDA was $647 million, up 16% year-over-year, with an Adjusted EBITDA margin of 15.2% versus 13.5% a year earlier. Non-GAAP diluted EPS was $3.21, up 22%. The company cited prudent cost management, improved program execution, and a $25 million insurance reimbursement for legal costs primarily incurred in prior periods as drivers of higher profitability. Cash flow from operations was $486 million and free cash flow was $457 million for the quarter. Investing activities were driven by the May 23, 2025 acquisition of Kudu Dynamics for preliminary purchase consideration of $291 million, net of $29 million cash acquired. As of July 4, 2025, the company had $930 million in cash and cash equivalents and $5.1 billion of debt. Net bookings were $3.9 billion, a book-to-bill ratio of 0.9, and backlog ended the quarter at $46.2 billion, of which $7.1 billion was funded. Leidos raised its fiscal 2025 guidance: revenues of $17.00 to $17.25 billion (prior $16.90 to $17.30 billion), adjusted EBITDA margin in the mid 13% range (prior mid-high 12%), non-GAAP diluted EPS of $11.15 to $11.45 (prior $10.35 to $10.75), and operating cash flow of approximately $1.65 billion (prior approximately $1.45 billion). The Board declared a quarterly cash dividend of $0.40 per share, payable September 30, 2025.

Aug 5, 2025
10-Q

Leidos Holdings Quarterly Report for Q2 Ended Jul 4, 2025

Leidos Holdings, Inc. reported higher second-quarter fiscal 2025 results, with revenues of $4,253 million, up from $4,132 million a year earlier (2.9%). Operating income rose to $571 million from $475 million (20.2%), and operating margin improved to 13.4% from 11.5%. Net income attributable to Leidos common stockholders was $391 million, and diluted EPS was $3.01 versus $2.37. For the six months, revenues were $8,498 million (4.8% higher), operating income was $1,101 million (23.7% higher), and diluted EPS was $5.80 versus $4.42. The company cited program wins, managed health services volume growth, and prior-year write-downs in its UK operations not recurring. Segment operating margins were 10.0% for National Security & Digital, 24.4% for Health & Civil, 7.1% for Commercial & International, and 7.6% for Defense Systems in the quarter. Backlog was $46,210 million at July 4, 2025, up from $41,551 million a year earlier (recast to include sole-source IDIQ task orders), and remaining performance obligations were $16 billion. Net bookings were $3.9 billion in the quarter and $6.0 billion for the six months. Leidos acquired Kudu Dynamics on May 23, 2025 for preliminary consideration of about $291 million net of cash acquired. Cash and cash equivalents were $930 million, and total long-term debt was $5,104 million, up from $4,670 million at fiscal year-end, after issuing $500 million of 5.40% notes due 2032 and $500 million of 5.50% notes due 2035. Quarterly dividends were $0.40 per share. The filing also states that the One Big Beautiful Bill Act reduces expected fiscal 2025 income taxes payable by approximately $280 million and federal and state tax payments by approximately $150 million. The company disclosed an ongoing Department of Justice Antitrust Division criminal investigation linked to a 2022 grand jury subpoena and an open SEC matter, and stated it cannot estimate potential fines or liabilities.

Aug 5, 2025
8-K

Leidos Holdings 8-K Report, Temporary Suspension of Trading Under Employee Benefit Plans (May 15, 2025)

Leidos Holdings, Inc. filed this Current Report to disclose a temporary suspension of trading under its employee benefit plan. On May 15, 2025, the administrator of the Leidos, Inc. Retirement Plan notified participants of a blackout period, which is required because the plan is undergoing administrative changes, including a recordkeeper change and a trustee change. During the blackout, participants cannot change contribution rates, direct or diversify investments (including in Leidos Holdings common stock), or take loans, withdrawals, or distributions from their plan accounts. The blackout is expected to begin during the calendar week of June 29, 2025, and end during the calendar week of July 20, 2025. The company also sent a notice to its directors and executive officers under Section 306 of the Sarbanes-Oxley Act of 2002 and Rule 104 of Regulation BTR. That notice states that, during the blackout period (from the afternoon of July 2, 2025 to the afternoon of July 25, 2025), these individuals generally may not buy, sell, or transfer Leidos equity securities received through their service, or trade derivatives referencing Leidos stock. The notice says this restriction is separate from, but overlaps with, the company's quarterly earnings blackout beginning June 15, 2025.

May 15, 2025
8-K

Leidos Holdings 8-K Report, Financial Results (May 6, 2025)

Leidos Holdings, Inc. (NYSE: LDOS) reported first-quarter fiscal 2025 results for the quarter ended April 4, 2025, with revenues of $4.25 billion, up 7% year-over-year, and net income of $365 million, or $2.77 per diluted share. Net income rose 29% and diluted EPS rose 34% year-over-year. Adjusted EBITDA was $601 million, up 23%, with a 14.2% margin versus 12.3% a year earlier. Non-GAAP diluted EPS was $2.97, up 30%. Management attributed the profitability gains primarily to increased volumes on managed health services programs and improved program execution and cost control. The company reaffirmed its fiscal 2025 guidance, including revenues of $16.90 to $17.30 billion, an adjusted EBITDA margin in the mid-to-high 12% range, non-GAAP diluted EPS of $10.35 to $10.75, and operating cash flow of approximately $1.45 billion. Cash generation was weaker in the quarter, with operating cash flow of $58 million and free cash flow (non-GAAP) of $36 million. The company issued $1.0 billion of senior unsecured notes due 2032 and 2035, used proceeds to retire $500 million of notes due May 2025, and repurchased $500 million of stock under an accelerated share repurchase agreement. Cash and cash equivalents were $842 million and debt totaled $5.1 billion as of April 4, 2025. Leidos also agreed to acquire a cyber platform developer for a preliminary price of $300 million, with closing expected in the second quarter of 2025. The filing also includes a revised backlog policy, effective in fiscal 2025, that adds estimated future revenue on expected sole source IDIQ task orders. Under this policy, backlog at the end of the quarter was $46.3 billion, of which $7.3 billion was funded, and net bookings were $2.1 billion, a book-to-bill ratio of 0.5. Exhibit 99.2 recasts backlog, bookings and book-to-bill for prior periods under the new policy.

May 6, 2025
10-Q

Leidos Holdings Quarterly Report for Q1 Ended Apr 4, 2025

Leidos Holdings, Inc. reported first-quarter fiscal 2025 results for the three months ended April 4, 2025. Revenues rose to $4,245 million from $3,975 million, a 6.8% increase. Operating income grew to $530 million from $415 million, a 27.7% increase, and operating margin improved to 12.5% from 10.4%. Net income attributable to Leidos common stockholders was $363 million versus $284 million, and diluted EPS was $2.77 compared with $2.07. The filing attributes segment gains mainly to higher volumes and program wins. Health & Civil operating income rose 34.7%, and Defense Systems operating income rose 61.9%. The company recorded net contract estimate changes that favorably affected income before taxes by $30 million, or $0.17 of diluted EPS. Cash flow and capital allocation shifted during the quarter. Net cash from operations was $58 million, down from $113 million, mainly due to the timing of payroll and employee benefit payments. In February 2025, Leidos issued $1.0 billion of senior notes due 2032 and 2035 and used the proceeds to retire $500 million of notes due May 2025 and fund a $500 million accelerated share repurchase. Total debt was $5.1 billion at April 4, 2025, up from $4.7 billion, and cash and cash equivalents were $842 million. The $1.0 billion revolving facility was undrawn, and the company was in compliance with its financial covenants. Backlog totaled $46,296 million, up from $41,683 million in the prior-year period, which the company recast to include estimated sole-source IDIQ task orders. Net bookings were $2.1 billion, compared with $3.8 billion a year earlier. Remaining performance obligations were $17 billion. The company also signed a definitive agreement on March 10, 2025 to acquire a cyber company for a preliminary price of $300 million, with closing expected in the second quarter of 2025. Government exposure remains high: about 87% of revenues came from U.S. government contracts, and the filing notes that the Department of Government Efficiency has led to contract cancellations, modifications and stop-work orders. The company also disclosed an ongoing SEC inquiry and a Department of Justice Antitrust Division grand jury investigation, and it said it cannot currently estimate any resulting fines or liabilities.

May 6, 2025
8-K

Leidos Holdings 8-K Report, Bylaw Amendment (May 6, 2025)

On May 2, 2025, Leidos Holdings, Inc. held its Annual Meeting of Stockholders, where shareholders elected all ten board nominees to one-year terms, approved on a non-binding advisory basis the compensation of the named executive officers, and ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending January 2, 2026. Stockholders also approved two amendments to the Amended and Restated Certificate of Incorporation: one clarifying stockholders' rights to call a special meeting, and one limiting the liability of officers as permitted by law. The Certificate of Amendment was filed with the Delaware Secretary of State on May 2, 2025 and became effective upon filing. The amendments had been approved by the Board and disclosed in the company's March 17, 2025 definitive proxy statement. For investors, the filing documents routine governance outcomes with no financial results reported. Director support was generally strong, though several nominees received notably higher against votes, including Patrick M. Shanahan (12,464,687 against) and Robert S. Shapard (11,556,925 against). The say-on-pay proposal received 90,205,635 votes for and 4,759,336 against, and both charter amendments passed with 86,888,456 and 83,966,415 votes for, respectively. The filing also includes Exhibit 3.1, the Certificate of Amendment, and Exhibit 104, the Inline XBRL cover page. No new financial statements or guidance are included in this 8-K.

May 6, 2025
8-K

Leidos Holdings 8-K Report, Corporate Update (Feb 25, 2025)

On February 20, 2025, Leidos, Inc., a direct wholly-owned subsidiary of Leidos Holdings, Inc., priced a cash tender offer for any and all of its outstanding 3.625% Senior Notes due 2025, with a Notes Consideration of $998.30 per $1,000 principal amount, plus accrued and unpaid interest from November 15, 2024. The tender offer expired at 5:00 p.m. New York City time on February 20, 2025. As of the expiration time, $267,393,000, or 53.48% of the $500 million principal amount outstanding, had been validly tendered and not validly withdrawn, excluding amounts submitted under guaranteed delivery procedures. Settlement was scheduled for February 25, 2025. On February 25, 2025, the issuer deposited funds with Citibank, N.A., as trustee, sufficient to repay the remaining 2025 Notes at their May 15, 2025 maturity. The indenture dated May 12, 2020 was thereby satisfied and discharged with respect to the 2025 Notes, releasing the issuer from its obligations under that indenture except for surviving provisions. The filing states the tender offer was funded using the proceeds of the issuer's February 20, 2025 sale of $500 million of 5.400% senior notes due 2032 and $500 million of 5.500% senior notes due 2035. The filing is a liability-management event that refinances existing debt with new notes and does not describe changes to operations, guidance, or financial results. It also reports that Leidos reported annual revenues of approximately $16.7 billion for the fiscal year ended January 3, 2025.

Feb 25, 2025
8-K

Leidos Holdings 8-K Report, Corporate Update (Feb 24, 2025)

Leidos Holdings, Inc. (the "Company") disclosed in a Form 8-K filed under Item 8.01 (Other Events) that on February 24, 2025 it announced it has entered into an accelerated share repurchase agreement (the "ASR Agreement") to repurchase $500 million of its common stock. The repurchases will be conducted under the Company's ongoing share repurchase authorization. Pursuant to the ASR Agreement, the Company made an initial payment of $500 million to the counterparty financial institution on February 20, 2025, and on the same day received initial deliveries of approximately 3 million shares of its common stock from the counterparty. The final number of shares to be repurchased will be based on the volume-weighted average stock price of the Company's common stock during the term of the ASR Agreement, less a discount and subject to adjustments under the agreement's terms. At settlement, the counterparty may under certain circumstances be required to deliver additional shares to the Company, or the Company may under certain circumstances be required to deliver shares or make a cash payment, at its election. Final settlement is expected during the second quarter of 2025, subject to earlier completion at the counterparty's option. The filing also references Exhibit 104, the cover page of the Form 8-K in Inline XBRL format.

Feb 24, 2025
8-K

Leidos Holdings 8-K Report, Material Agreement (Feb 20, 2025)

On February 20, 2025, Leidos, Inc., a direct wholly-owned subsidiary of Leidos Holdings, Inc., issued and sold $500 million of 5.400% senior notes due 2032 and $500 million of 5.500% senior notes due 2035, for a total of $1.0 billion in aggregate principal. The notes are senior unsecured obligations of Leidos, Inc. and are guaranteed by Leidos Holdings, Inc. The offering was made under an automatic shelf registration statement on Form S-3 and issued under an October 2020 indenture with Citibank, N.A. as trustee. The company stated it intends to use the net proceeds for general corporate purposes, including repurchasing for cash any and all of its outstanding 3.625% notes due 2025 tendered in a tender offer, repaying any remaining 2025 notes, repaying a portion of its senior unsecured term loan facility, repurchasing outstanding common stock, funding potential acquisitions, and paying related fees and expenses. Until applied, remaining proceeds may be invested in short-term, liquid investments. The notes pay interest semi-annually on March 15 and September 15, beginning September 15, 2025, and mature on March 15, 2032 and March 15, 2035, respectively. Each series is redeemable at a make-whole premium before its applicable par call date (January 15, 2032 for the 2032 notes and December 15, 2034 for the 2035 notes), and at 100% of principal plus accrued interest thereafter. Upon a change of control triggering event, the issuer must offer to repurchase the notes at 101% of principal plus accrued interest.

Feb 20, 2025
8-K

Leidos Holdings 8-K Report, Corporate Update (Feb 13, 2025)

Leidos Holdings, Inc. (NYSE: LDOS) announced on February 13, 2025 that its wholly-owned subsidiary, Leidos, Inc., commenced a cash tender offer to purchase any and all of its outstanding 3.625% Senior Notes due 2025 (the "2025 Notes"). The filing states that $500,000,000 in principal amount of the 2025 Notes is currently outstanding. The tender offer is governed by an Offer to Purchase dated February 13, 2025, and is scheduled to expire at 5:00 p.m. Eastern Time on February 20, 2025, unless extended or earlier terminated. Holders who validly tender their notes will receive the "Notes Consideration" per $1,000 principal amount, calculated by reference to a fixed spread of +0 bps over the yield on the 2.125% U.S. Treasury due May 15, 2025, plus accrued and unpaid interest from the November 15, 2024 interest payment date. The expected settlement date is February 25, 2025. Holders may withdraw tendered notes within specified periods, and the tender offer is conditioned on Leidos successfully completing a separate offering of new senior notes generating sufficient net proceeds to fund the repurchase and any required satisfaction and discharge of remaining 2025 Notes. That offering is not conditioned on completion of the tender offer. Citigroup Global Markets Inc., J.P. Morgan Securities LLC and U.S. Bancorp Investments, Inc. are acting as Dealer Managers, and Global Bondholder Services Corporation is the depositary and information agent. The release states that Leidos is not making any recommendation on whether holders should tender. The filing also notes Leidos reported annual revenues of approximately $16.7 billion for the fiscal year ended January 3, 2025.

Feb 13, 2025
8-K

Leidos Holdings 8-K Report, Financial Results (Feb 11, 2025)

Leidos Holdings, Inc. reported financial results for its fourth quarter and fiscal year ended January 3, 2025, as furnished in Exhibit 99.1 (press release dated February 11, 2025). Fourth-quarter revenues were $4.37 billion, up 10% year-over-year, and net income was $282 million, or $2.12 per diluted share. For the full year, revenues were $16.66 billion, up 8%, and net income was $1,251 million, or $9.22 per diluted share, compared with $208 million, or $1.44 per diluted share, in fiscal 2023, which included goodwill and asset impairment and restructuring charges tied to the Security Enterprise Solutions reporting unit. Non-GAAP diluted EPS was $2.37 for the quarter (up 19%) and $10.21 for the year (up 40%). Adjusted EBITDA for the year was $2.15 billion, a 12.9% margin. Cash flow and backlog were strong. Net cash provided by operating activities was $299 million in the quarter and $1.39 billion for the year, with free cash flow of $1.24 billion for the year. The company returned $459 million to shareholders in the quarter, including $406 million in share repurchases. Net bookings were $23.4 billion for fiscal 2024, a book-to-bill ratio of 1.4, and backlog ended the year at $43.6 billion. Cash and cash equivalents were $943 million and debt was $4.7 billion at year-end. For fiscal 2025, Leidos guided to revenues of $16.9 to $17.3 billion, an adjusted EBITDA margin in the mid-to-high 12% range, non-GAAP diluted EPS of $10.35 to $10.75, and operating cash flow of approximately $1.45 billion. The Board also declared a quarterly cash dividend of $0.40 per share, payable March 28, 2025, to holders of record on March 14, 2025.

Feb 11, 2025
10-K

Leidos Holdings Annual Report, Year Ended Jan 3, 2025

Leidos Holdings, Inc. ("Leidos"), a holding company whose principal operating subsidiary is Leidos, Inc., reported fiscal 2024 (ended January 3, 2025) revenues of $16.66 billion, up 8% from $15.44 billion in fiscal 2023. Operating income rose to $1.83 billion, compared with $621 million in fiscal 2023, which had included $689 million of impairment and restructuring charges at the Security Enterprise Solutions (SES) reporting unit. Operating margin was 11.0% versus 4.0% a year earlier. Net income attributable to Leidos common stockholders was $1.25 billion ($9.22 diluted EPS), compared with $199 million in fiscal 2023. Approximately 87% of revenues came from U.S. government contracts, and about 8% came from entities outside the United States. Net bookings were $23.4 billion in fiscal 2024, versus $16.5 billion in fiscal 2023, and total backlog stood at $43.6 billion, including $8.4 billion of funded backlog. Operating cash flow was $1.39 billion. Cash and cash equivalents were $943 million at year-end, and total debt was $4.7 billion. The company paid $850 million in open-market share repurchases during fiscal 2024 and $208 million in dividends, with dividends declared at $1.54 per share. The filing describes a realignment into four reportable segments (National Security & Digital, Health & Civil, Commercial & International, and Defense Systems). Health & Civil revenue grew 18% to $5.02 billion with operating margin of 21.8%. The filing also flags risks including dependence on U.S. government budgets and appropriations, the continuing resolution that runs through March 14, 2025, competitive bid protests, and fixed-price contract cost overruns. Goodwill was 46% of total assets. The company disclosed a Department of Justice Antitrust Division grand jury subpoena and an SEC inquiry related to past international operations, and the Department of Justice closed its separate inquiry in December 2024.

Feb 11, 2025
8-K

Leidos Holdings 8-K Report, Executive Changes (Jan 14, 2025)

Leidos Holdings, Inc. filed this Current Report on Form 8-K dated January 14, 2025 (event date January 13, 2025) to disclose a leadership change. On January 13, 2025, Gerard A. Fasano, Chief Growth Officer, informed the company of his intention to retire, effective April 4, 2025, following a career the filing describes as spanning over 40 years. The filing is narrow in scope. It contains no financial results, guidance, or financial statements, and it reports no other material events. The only item disclosed is under Item 5.02, Departure of Directors or Principal Officers, and the only exhibit is the Inline XBRL cover page (Exhibit 104). The report was signed by Brian Z. Liss, SVP, Deputy General Counsel and Corporate Secretary. For investors, the key takeaway is a scheduled executive departure with a defined effective date, giving the company several months to plan a transition for the Chief Growth Officer role. The filing does not name a successor or describe any transition arrangements.

Jan 14, 2025
8-K

Leidos Holdings 8-K Report, Financial Results (Oct 29, 2024)

Leidos Holdings, Inc. reported financial results for its third fiscal quarter ended September 27, 2024, in a press release furnished as Exhibit 99.1 to this Form 8-K. Revenues were $4.19 billion, up 7% year-over-year, and net income was $362 million, or $2.68 per diluted share, compared with a net loss of $396 million in the prior-year quarter, which included a $699 million pre-tax, non-cash impairment and restructuring charge primarily tied to the Security Enterprise Solutions (SES) reporting unit. Adjusted EBITDA was $596 million with a record 14.2% margin, up from 11.5%, and non-GAAP diluted EPS was $2.93, up 44% year-over-year. Cash flow from operations was $656 million and free cash flow (non-GAAP) was $633 million. Net bookings were $8.1 billion for the quarter, a book-to-bill ratio of 1.9, and backlog ended the quarter at $40.6 billion, of which $9.1 billion was funded. Notable awards included a five-year, $331 million Army Global Unified Network contract and a five-year, $303 million Air Force ABMS-DI network contract. The company raised its fiscal 2024 guidance: revenues are now expected at $16.35 to $16.45 billion (previously $16.10 to $16.40 billion), non-GAAP diluted EPS at $9.80 to $10.00 (previously $8.60 to $9.00), and adjusted EBITDA margin at high-12% (previously approximately 12%). The company also declared a quarterly dividend of $0.40 per share, a 5.3% increase over the prior quarter's dividend, payable December 31, 2024. As of September 27, 2024, Leidos had $1,185 million in cash and cash equivalents and $4.7 billion of debt, and it repurchased $203 million of stock during the quarter.

Oct 29, 2024
10-Q

Leidos Holdings Quarterly Report for Q3 Ended Sep 27, 2024

Leidos Holdings, Inc. reported third-quarter 2024 revenues of $4.19 billion, up from $3.92 billion in the prior-year quarter, a 6.9% increase. Operating income was $516 million, a 12.3% operating margin, compared with an operating loss of $336 million in the year-earlier quarter, which included a $599 million goodwill impairment and an $88 million asset impairment. Net income attributable to Leidos common stockholders was $364 million, or $2.68 diluted EPS, versus a loss of $399 million, or $(2.91) per diluted share, a year earlier. For the nine months, revenues rose 7.3% to $12.30 billion, operating income was $1.41 billion (11.4% operating margin), and diluted EPS was $7.13. The company reported net bookings of $8.1 billion in the quarter and $15.8 billion for the nine months, compared with $7.9 billion and $13.8 billion a year earlier. Total backlog was $40.56 billion at September 27, 2024, up from $38.04 billion, and remaining performance obligations were $16 billion. Health & Civil was the strongest segment, with a 23.4% operating margin in the quarter. Cash and cash equivalents increased to $1.19 billion from $0.78 billion at fiscal year-end 2023, and nine-month operating cash flow was $1.09 billion, compared with $0.86 billion a year earlier. Quarterly operating cash flow of $656 million was lower than the $795 million reported in the prior-year quarter. The filing also discloses an ongoing internal investigation into international operations, which the company has self-reported to the Department of Justice and the SEC, along with a separate Department of Justice Antitrust Division criminal investigation. The company states it cannot predict the timing, outcome, or possible impact of these matters. Shareholder returns included quarterly dividends of $0.38 per share and open-market share repurchases of $450 million over the nine months.

Oct 29, 2024
8-K

Leidos Holdings 8-K Report, Executive Changes (Oct 25, 2024)

On October 25, 2024, the Board of Directors of Leidos Holdings, Inc. approved and adopted amendments to the Company's Amended and Restated Bylaws, effective as of that same date. The amendments clarify and implement procedural and disclosure requirements for stockholders seeking to nominate directors or propose business at annual or special meetings, and they conform the bylaws to developments in Delaware General Corporation Law. The filing also describes other technical, conforming, clarifying and modernizing revisions. Among the changes, the amendments clarify procedural requirements for the form of delivery of notices and the number of nominees a stockholder may nominate. They expand disclosure requirements to cover additional information about the nominating or proposing stockholder, the director nominees, and their control persons, and require that this information be updated and supplemented to remain accurate and timely. They also require a stockholder nominating directors under Rule 14a-19 to represent whether it intends to solicit holders of at least 67% of the voting power entitled to vote on the election of directors, and to provide reasonable evidence of compliance with the rules. The filing describes the bylaw changes as governance housekeeping and procedural tightening rather than a change to leadership or compensation. The full text of the amended bylaws is filed as Exhibit 3.2, and the filing includes the Inline XBRL cover page as Exhibit 104.

Oct 25, 2024
8-K

Leidos Holdings 8-K Report, Executive Changes (Sep 18, 2024)

Leidos Holdings, Inc. filed this Current Report on Form 8-K to disclose the appointment of Tina W. Jonas as a Director. On September 12, 2024, the Board increased its size to 13 members and elected Ms. Jonas, effective September 25, 2024. The Board has determined she is independent under New York Stock Exchange requirements, and she has been appointed to the Audit and Finance Committee effective on the same date. She will receive standard non-employee director compensation as described in the company's proxy statement filed on March 12, 2024. The filing states there are no arrangements or understandings between Ms. Jonas and any other person under which she was selected as a director, and no related-person transactions under Item 404(a) of Regulation S-K requiring disclosure. The item is a governance change rather than a financial event, and the filing contains no financial results, guidance, or quantitative financial data. The accompanying press release (Exhibit 99.1), dated September 18, 2024, describes Ms. Jonas's background in the federal government and the aerospace and defense industry, including her service as Undersecretary of Defense (Comptroller) and as chief financial officer of the Federal Bureau of Investigation. It also notes that she serves on the boards of Virgin Galactic Holdings, Inc. and Centrus Energy Corporation. The release reports that Leidos had approximately $15.4 billion in revenue for the fiscal year ended December 29, 2023, and has a global workforce of 48,000.

Sep 18, 2024
10-Q

Leidos Holdings Quarterly Report for Q2 Ended Jun 28, 2024

Leidos Holdings, Inc. reported revenues of $4.13 billion for the three months ended June 28, 2024, up from $3.84 billion a year earlier, and $8.11 billion for the six months, compared with $7.54 billion. Operating income rose to $475 million for the quarter from $331 million, and to $890 million for the six months from $596 million. Net income attributable to Leidos common stockholders was $322 million for the quarter ($2.37 diluted EPS) versus $207 million ($1.50 diluted EPS) a year earlier. The filing notes that results include $39 million in write-downs on programs within the UK operations related to cost increases and schedule delays, and that the Commercial & International segment posted an operating loss of $11 million for the quarter. Bookings and backlog were strong. Net bookings were an estimated $4.0 billion for the quarter and $7.7 billion for the six months, compared with $2.9 billion and $5.9 billion a year earlier. Total backlog was $36.5 billion at June 28, 2024, versus $34.2 billion at June 30, 2023. Net cash provided by operating activities was $437 million for the six months, up from $66 million, and cash and cash equivalents stood at $823 million. Total debt was $4.7 billion, and the company repurchased $250 million of common stock in the six months while paying $104 million in dividends. The filing also discloses ongoing government matters. Leidos is conducting an internal investigation into international operations that may have violated the U.S. Foreign Corrupt Practices Act, has self-reported to the Department of Justice and the SEC, and is cooperating with both agencies. It also received a Department of Justice Antitrust Division grand jury subpoena in August 2022 related to three U.S. Government procurements, and states it cannot currently estimate any resulting fines or penalties.

Jul 30, 2024
8-K

Leidos Holdings 8-K Report, Financial Results (Jul 30, 2024)

Leidos Holdings, Inc. reported second-quarter fiscal 2024 results for the quarter ended June 28, 2024, with revenues of $4.13 billion, up 8% year-over-year, and net income of $324 million, or $2.37 per diluted share, compared with $210 million, or $1.50 per diluted share, a year earlier. Adjusted EBITDA (non-GAAP) was $559 million, up 33%, at a record 13.5% margin, and non-GAAP diluted EPS was $2.63, up 46%. Management attributed the higher profitability to increased volumes, higher earned incentives on managed health services, and improved cost control. Health & Civil was the main driver, with operating income margin of 24.3% versus 13.0% a year earlier. Commercial & International was the weak spot, with an operating margin of (2.0)%, which the filing attributes to UK contract adjustments. Cash performance was strong. Operating cash flow was $374 million and free cash flow (non-GAAP) was $351 million, with an operating cash flow conversion ratio of 116% and a non-GAAP free cash flow conversion ratio of 98%. Days sales outstanding was 58, a 1-day improvement. The company returned $165 million to shareholders in the quarter, including $114 million in share repurchases and $51 million in dividends. Net bookings were $4.0 billion, a book-to-bill ratio of 1.0 for the quarter and 1.1 for the trailing twelve months, and backlog ended the quarter at $36.5 billion, of which $8.0 billion was funded. Leidos raised its fiscal 2024 guidance for revenues to $16.1 to $16.4 billion (from $16.0 to $16.4 billion), adjusted EBITDA margin to approximately 12% (from mid-to-high 11%), and non-GAAP diluted EPS to $8.60 to $9.00 (from $8.40 to $8.80). Operating cash flow guidance was unchanged at approximately $1.3 billion. The board declared a quarterly dividend of $0.38 per share, payable September 27, 2024.

Jul 30, 2024
8-K

Leidos Holdings 8-K Report, Financial Results (Apr 30, 2024)

Leidos Holdings, Inc. reported first-quarter fiscal 2024 results for the quarter ended March 29, 2024, in a press release furnished as Exhibit 99.1 to this Form 8-K. Revenues were $3,975 million, up 7% from $3,699 million a year earlier, driven by increased demand across all customer segments, especially managed health services. Net income rose to $283 million, or $2.07 per diluted share, from $164 million, or $1.17 per diluted share. Adjusted EBITDA was $490 million, a 12.3% margin compared with 9.4% in the prior-year quarter, and non-GAAP diluted EPS was $2.29, up 56% year-over-year. The company attributed the profitability gains primarily to higher volumes on fixed-rate managed health services and improved cost control. Cash generation and capital returns were mixed in the quarter. Net cash provided by operating activities was $63 million and non-GAAP free cash flow was $46 million, compared with a use of $98 million in operating cash flow in the prior-year quarter. Leidos returned $236 million to shareholders, including $183 million in share repurchases and $53 million in dividends. Net bookings were $3.7 billion, a book-to-bill ratio of 0.9 for the quarter and 1.1 for the trailing twelve months, and backlog ended the quarter at $36.6 billion, of which $8.0 billion was funded. The company raised its fiscal 2024 guidance for revenues, adjusted EBITDA margin, non-GAAP diluted EPS and operating cash flow, and declared a quarterly dividend of $0.38 per share payable June 28, 2024.

Apr 30, 2024
10-Q

Leidos Holdings Quarterly Report for Q1 Ended Mar 29, 2024

Leidos Holdings, Inc. reported first-quarter 2024 revenues of $3,975 million, up 7.5% from $3,699 million in the prior-year quarter. Operating income rose to $415 million from $265 million, lifting operating margin to 10.4% from 7.2%. Net income attributable to Leidos common stockholders was $284 million, compared with $162 million, and diluted EPS was $2.07 versus $1.17. The filing attributes the growth mainly to higher volumes and program wins, with Health & Civil the largest contributor. Health & Civil revenue grew 18.9% to $1,199 million, and its operating income more than doubled to $222 million, reflecting higher managed health services volumes and favorable business mix. The company's balance sheet and liquidity remained stable. Cash and cash equivalents were $633 million, outstanding debt was $4.7 billion, and there were no borrowings under the $1 billion revolving facility. Operating cash flow was $63 million, compared with negative $98 million a year earlier, mainly due to lower tax payments. The company returned capital through $53 million in dividends and open market repurchases of about $150 million. Total backlog was $36.6 billion, net bookings were an estimated $3.7 billion, and remaining performance obligations were $14.3 billion. The filing also discloses ongoing legal and regulatory matters. Leidos is conducting an internal investigation into international operations that may have violated the FCPA, has self-reported to the DOJ and SEC, and cannot anticipate the timing or outcome. A separate DOJ Antitrust Division grand jury subpoena relates to three U.S. government procurements, and the company states it cannot reasonably estimate potential penalties. The VirnetX Apple II patent case concluded on February 20, 2024, with no proceeds received by Leidos.

Apr 30, 2024
8-K

Leidos Holdings 8-K Report, Shareholder Vote Results (Apr 29, 2024)

At its Annual Meeting of Stockholders held on April 26, 2024, Leidos Holdings, Inc. shareholders elected all twelve board nominees, each for a one-year term, including Thomas A. Bell, Gregory R. Dahlberg, David G. Fubini, Noel B. Geer, Robert C. Kovarik, Jr., Harry M. J. Kraemer, Jr., Gary S. May, Surya N. Mohapatra, Nancy A. Norton, Patrick M. Shanahan, Robert S. Shapard, and Susan M. Stalnecker. Stockholders also approved, on a non-binding advisory basis, the compensation of the named executive officers, and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending January 3, 2025. A stockholder proposal regarding a special shareholder meeting improvement was not approved, with 26,398,569 votes for, 78,599,578 against, and 799,096 abstentions. The Board intends to propose amendments at the 2025 Annual Meeting to the Certificate of Incorporation's special meeting provisions so they conform to the special meeting provisions in the Bylaws adopted by the Board on February 8, 2024. Until those amendments take effect, special meetings may be called under the Certificate of Incorporation or under Section 2.02(a) of the Bylaws. The filing is a voting results report under Item 5.07 and contains no financial results, guidance, or transaction disclosures; its exhibit is the Inline XBRL cover page.

Apr 29, 2024
10-K

Leidos Holdings Annual Report, Year Ended Dec 29, 2023

Leidos Holdings, Inc. ("Leidos") reported fiscal 2023 revenues of $15.44 billion, up $1.04 billion (7%) from $14.40 billion in fiscal 2022, driven by program wins, higher volumes and acquisitions. Operating income fell 43% to $621 million, from $1.088 billion, primarily because of a $596 million non-cash goodwill impairment charge at the Security Enterprise Solutions (SES) reporting unit, within the Civil segment, and $91 million of asset impairment charges. Net income attributable to common stockholders dropped to $199 million, or $1.44 diluted EPS, from $685 million and $4.96 a year earlier. The effective tax rate rose to 48.4% from 21.8%, mainly because the goodwill impairment is not tax deductible. The company generated 87% of revenues from U.S. government contracts, and revenues under contracts with the DoD and U.S. Intelligence Community represented approximately 49% of total revenues. Funded backlog ended the year at $8.8 billion, and total backlog reached $37.0 billion. Net bookings were $16.5 billion. Operating cash flow rose to $1.165 billion from $992 million, and cash and cash equivalents ended at $777 million. Total debt was $4.7 billion, and the company paid $201 million in dividends. Management flagged a $260 million increase in tax payments tied to the Tax Cuts and Jobs Act provision requiring amortization of R&D costs, and it expects a further increase of about $60 million in fiscal 2024. The filing also discloses ongoing matters that investors should weigh. These include an internal investigation into international operations, self-reported to the Department of Justice and the SEC, a DOJ Antitrust Division grand jury subpoena, and uncertain proceeds from the VirnetX patent litigation. Beginning in fiscal 2024, Leidos will report four segments instead of three. The company is also subject to ongoing DCAA audits and government contracting risks. Its stock is listed on the NYSE under the ticker LDOS.

Feb 13, 2024
8-K

Leidos Holdings 8-K Report, Financial Results (Feb 13, 2024)

Leidos Holdings, Inc. (NYSE: LDOS) reported fourth-quarter and fiscal 2023 results on February 13, 2024, with revenues of $3.98 billion for the quarter (up 8% year-over-year) and $15.44 billion for the year (up 7%). Diluted EPS was $1.66 for the quarter (up 30%) and $1.44 for the year (down 71%). The company said the annual decline was primarily due to pre-tax impairment and restructuring charges of $699 million, mainly associated with the Security Enterprise Solutions (SES) reporting unit recorded in the third quarter. Non-GAAP diluted EPS was $1.99 for the quarter (up 9%) and $7.30 for the year (up 11%), and adjusted EBITDA was $1.67 billion (10.8% margin) for the year. Cash performance was solid: net cash provided by operating activities was $304 million in the quarter and $1.17 billion for the year, with free cash flow of $958 million for the year. The company returned $253 million to shareholders in the quarter, including $202 million in share repurchases, and declared a $0.38 per share dividend payable March 28, 2024. Net bookings were $16.5 billion for fiscal 2023, with a year-end backlog of $37.0 billion, of which $8.8 billion was funded. Leidos initiated fiscal 2024 guidance calling for revenues of $15.7 to $16.1 billion, an adjusted EBITDA margin in the mid-to-high 10% range, non-GAAP diluted EPS of $7.50 to $7.90, and operating cash flow of approximately $1.1 billion. The filing also reports that, effective December 30, 2023, the company adopted a new four-segment structure, with recast historical information provided in Exhibit 99.2.

Feb 13, 2024
8-K

Leidos Holdings 8-K Report, Executive Changes (Jan 17, 2024)

Leidos Holdings, Inc. (NYSE: LDOS) announced on January 17, 2024 that Jerald S. Howe, Jr. will leave his role as General Counsel and Corporate Secretary effective April 1, 2024, as part of his planned retirement. Mr. Howe will remain in a full-time advisory role on the same terms and conditions of employment through July 31, 2024, and then in a more limited consulting capacity through March 15, 2025. The Company entered into a Consulting Employee Agreement with him, dated January 17, 2024 and effective April 1, 2024, under which he will be paid $1,200 per hour, with working hours not to exceed 1,860 hours in any 12-month period. The agreement also provides continued medical insurance eligibility and continued participation in the Leidos Retirement Plan. The Board of Directors appointed Daniel J. Antal, age 52, as General Counsel and Corporate Secretary, effective April 1, 2024. Mr. Antal most recently served as General Counsel for Rolls-Royce Defense and North America. He previously spent more than seven years at Leidos, including as general counsel for defense and corporate secretary, and later supported the Company's former Civil group. He holds an MBA from the University of Denver Daniels Business College and a JD from the University of Denver Sturm College of Law. The accompanying press release, furnished as Exhibit 99.1, quotes CEO Tom Bell welcoming Mr. Antal back to the Company and thanking Mr. Howe for his service. The Company describes itself as having 47,000 employees and reported annual revenues of approximately $14.4 billion for the fiscal year ended December 30, 2022.

Jan 17, 2024
8-K

Leidos Holdings 8-K Report, Executive Changes (Dec 14, 2023)

Leidos Holdings, Inc. filed a Current Report on Form 8-K reporting two governance-related actions taken by its Board of Directors on December 11, 2023. First, the Board increased its size to 13 members and elected Vice Admiral (Retired) Nancy Ann Norton as a Director, effective January 1, 2024. The Board determined Ms. Norton is independent under New York Stock Exchange requirements, and she will receive standard non-employee director compensation as described in the company's March 15, 2023 proxy statement. She has not been appointed to any Board committees at this time. The filing also states there are no arrangements or material related-person transactions involving Ms. Norton requiring disclosure. Second, the Board appointed Daniel A. Atkinson IV, age 45, as Senior Vice President, Chief Accounting Officer and Corporate Controller, effective upon the filing of the Form 10-K for the year ended December 29, 2023. Mr. Atkinson previously served as Assistant Corporate Controller since June 2021 and was earlier Director of Technical Accounting and Revenue Recognition at Booz Allen Hamilton. Beginning January 8, 2024, he will receive a base salary of $340,000, a target cash bonus of 50% of base salary, and a fiscal year 2024 equity award with a grant date fair value of $204,000, split 50% performance shares, 30% performance restricted stock units and 20% stock options. Carly E. Kimball will remain Chief Accounting Officer and Corporate Controller until that effective date and will also become Chief Performance Officer on January 1, 2024. For investors, the filing describes leadership and board refreshment rather than financial results. The filing does not report earnings, revenue or guidance. Exhibit 99.1 is a press release dated December 14, 2023, announcing Ms. Norton's appointment.

Dec 14, 2023
8-K

Leidos Holdings 8-K Report, Executive Changes (Nov 2, 2023)

Leidos Holdings, Inc. filed this Form 8-K on November 2, 2023 to report executive appointments and a realignment of its operating groups, both effective January 1, 2024. Under Item 5.02, the Board on October 27, 2023 appointed Gerard A. Fasano, currently President of the Defense Group since October 2018, as Executive Vice President, Chief Growth Officer, and appointed Carly E. Kimball, currently Senior Vice President and Chief Accounting Officer and Corporate Controller since July 2021, as Executive Vice President, Chief Performance Officer. Fasano's role will fuse strategy, marketing, sales, government affairs, and communications into one growth function, while Kimball's will cover program execution, real estate, security, IT, and procurement to drive operational excellence. Under Item 7.01, the company furnished Exhibit 99.1, a press release dated November 2, 2023, announcing that Leidos will be organized into five sectors: Health and Civil, National Security, Commercial and International, Digital Modernization, and Defense Systems, with Leidos Dynetics continuing under President Steve Cook. Cindy Gruensfelder joins as president of the Defense Systems Sector. The press release states that Jim Carlini, Jerry Howe, Maureen Waterston, and Chris Cage will continue in their current roles as CTO, General Counsel, CHRO, and CFO, respectively. Per the release, the company reported approximately $14.4 billion in annual revenue for fiscal 2022 and has 47,000 employees. The filing is largely organizational and does not disclose financial results, guidance, or quantified financial impacts from these changes. The information under Item 7.01 is furnished rather than filed for purposes of Section 18 of the Exchange Act.

Nov 2, 2023
10-Q

Leidos Holdings Quarterly Report for Q3 Ended Sep 29, 2023

Leidos Holdings, Inc. reported a net loss in the third quarter of fiscal 2023 (ended September 29, 2023) driven by a non-cash goodwill impairment charge of $599 million and an intangible asset impairment charge of $79 million, both tied to its Security Enterprise Solutions (SES) reporting unit within the Civil segment. Revenues grew to $3.92 billion in the quarter from $3.61 billion a year earlier, and operating results swung to a loss of $336 million from income of $281 million. For the nine months, revenues were $11.46 billion and net loss was $22 million, compared with net income of $513 million in the prior-year period. The filing states that the impairment followed reduced forecasts for SES, which was hurt by delays in airline travel infrastructure projects, and that SES's remaining goodwill is $303 million, with possible further impairments if forecasts worsen. Segment results show Defense Solutions and Health growing, with Defense Solutions quarterly revenue of $2.22 billion and Health revenue of $776 million, while Civil operating results were negative due to the impairments. Total backlog stood at $38.04 billion and net bookings were $7.9 billion in the quarter and $13.8 billion for the nine months. Debt totaled roughly $4.7 billion, cash and equivalents were $750 million, and the company refinanced its term loans in March 2023 under a new $1.0 billion term loan and $1.0 billion revolving facility maturing in March 2028. The filing also discloses ongoing uncertainty around the VirnetX/Apple patent matter, a self-reported FCPA-related internal investigation, and a DOJ Antitrust Division grand jury subpoena.

Oct 31, 2023
8-K

Leidos Holdings 8-K Report, Financial Results (Oct 31, 2023)

Leidos Holdings, Inc. (NYSE: LDOS) reported results for its third fiscal quarter of 2023, ended September 29, 2023. Revenues were $3.92 billion, up 9% year-over-year, driven by increased demand across all customer segments, especially digital modernization and medical examination solutions. The company reported a net loss of $396 million, or $2.91 per diluted share, which reflected pre-tax, non-cash impairment and restructuring charges of $699 million, primarily associated with the Security Enterprise Solutions (SES) reporting unit. Non-GAAP diluted EPS was $2.03, up 28% year-over-year, and Adjusted EBITDA was $451 million, an 11.5% margin versus 10.3% a year earlier. Cash flow was strong, with $795 million of net cash provided by operating activities and free cash flow of $745 million, aided in part by U.S. Government customers accelerating payments at their fiscal year end. Net bookings totaled $7.9 billion, a book-to-bill ratio of 2.0 for the quarter, and backlog reached $38.0 billion, of which $9.0 billion was funded. Management raised all of its FY23 guidance metrics, including revenues of $15.1 to $15.3 billion, Adjusted EBITDA margin of 10.5% to 10.7%, non-GAAP diluted EPS of $6.80 to $7.10, and operating cash flow at or above $850 million. The Board also declared a quarterly dividend of $0.38 per share, an increase of 6% over the prior quarter's dividend. The headline GAAP loss is driven by the non-cash charges tied to the SES unit, which the company recorded as a $599 million goodwill impairment and $88 million of asset impairments in the quarter. Investors will likely focus on whether the strong bookings, improved guidance, and higher non-GAAP profitability in Defense Solutions and Health offset the impairment-driven weakness in the Civil segment, which posted an operating loss of $607 million for the quarter.

Oct 31, 2023
10-Q

Leidos Holdings Quarterly Report for Q2 Ended Jun 30, 2023

Leidos Holdings, Inc. (LDOS) reported higher revenue and profitability for the second quarter and first half of fiscal 2023. Revenues for the three months ended June 30, 2023 were $3,838 million, up from $3,597 million a year earlier, and operating income rose to $331 million from $271 million. For the six months, revenues were $7,537 million versus $7,091 million, and operating income was $596 million versus $542 million. Net income attributable to Leidos common stockholders was $207 million for the quarter, with diluted EPS of $1.50 versus $1.24. Operating margin was 8.6% for the quarter compared with 7.5% in the prior-year quarter. Defense Solutions, Civil and Health all reported higher revenues for the quarter, and Health's operating income declined year over year due to a prior-year $28 million COVID-19 stop-work recovery. Cash flow and balance sheet activity were more mixed. Net cash provided by operating activities was $66 million for the six months, down from $138 million, reflecting higher tax payments. Total debt was $4.9 billion at June 30, 2023, unchanged from year-end. During the first quarter, Leidos issued $750 million of 5.75% senior notes due 2033 and entered into a $1.0 billion term loan facility and a $1.0 billion revolving facility, both maturing in March 2028. Cash and cash equivalents were $329 million. The company paid $0.36 per share in quarterly dividends and made no share repurchases in the second quarter. Total backlog was $34,152 million at June 30, 2023, compared with $34,722 million a year earlier, and second-quarter net bookings were $2.9 billion. Investors should note several disclosed legal and regulatory matters. The company is conducting an internal investigation into international operations that it has self-reported to the Department of Justice and the SEC, and it received a federal grand jury subpoena in connection with that matter. A separate grand jury subpoena from the Department of Justice Antitrust Division relates to three U.S. Government procurements. The company also holds a potential interest in VirnetX patent litigation proceeds, but the filing states that no assurances can be given when or if any proceeds will be received.

Aug 1, 2023
8-K

Leidos Holdings 8-K Report, Financial Results (Aug 1, 2023)

Leidos Holdings, Inc. reported financial results for its second fiscal quarter ended June 30, 2023, in a press release furnished as Exhibit 99.1 to this Form 8-K. Revenues were $3.84 billion, up 7% year-over-year, driven by demand across all customer segments, especially digital modernization, hypersonics, and medical examinations solutions. Net income was $210 million (a 5.5% margin), diluted EPS was $1.50, and adjusted EBITDA was $420 million (a 10.9% margin), with non-GAAP diluted EPS of $1.80. Cash flow from operations was $164 million and free cash flow was $124 million. Net bookings were $2.9 billion, a book-to-bill ratio of 0.8, and backlog ended the quarter at $34.2 billion, of which $8.3 billion was funded. The company updated its fiscal 2023 guidance. Revenue guidance was raised to $14.9 billion to $15.2 billion from $14.7 billion to $15.1 billion, and the adjusted EBITDA margin range narrowed to 10.1% to 10.5% from 10.3% to 10.5%. Non-GAAP diluted EPS guidance of $6.40 to $6.80 and operating cash flow of at or above $700 million were unchanged. Management also highlighted a shift toward a sharper focus on earnings and cash alongside top-line growth. The company declared a quarterly dividend of $0.36 per share, payable September 29, 2023. Cash and cash equivalents were $329 million and total debt was $4.9 billion at quarter-end.

Aug 1, 2023
8-K

Leidos Holdings 8-K Report, Material Agreement (Jun 1, 2023)

Leidos Holdings, Inc. (LDOS) reported in this Form 8-K filed June 1, 2023 that its wholly-owned subsidiary, Leidos, Inc. (the Issuer), increased the size of its existing commercial paper program by $250 million on May 26, 2023. The program was originally entered into on July 12, 2021, and the aggregate face or principal amount of notes outstanding at any time may not exceed $1,000,000,000. Leidos Holdings, Inc. unconditionally guarantees the notes. The notes may have maturities of up to 397 days and are unsecured, ranking at least pari passu with the Issuer's other unsecured, unsubordinated indebtedness. Proceeds are expected to be used for general corporate purposes, which may include working capital, capital expenditures, acquisitions and share repurchases. The company expects its revolving credit facilities of the Issuer and the Guarantor to serve as liquidity backstops for issuances under the program. The notes were offered under the Section 4(a)(2) exemption from registration and have not been registered under the Securities Act or state securities laws. The filing also discloses that dealers and certain of their affiliates have provided, and may in the future provide, lending, commercial banking, investment banking and other financial advisory services to the company. The form of dealer agreement is filed as Exhibit 10.1, incorporated by reference from the July 12, 2021 Form 8-K.

Jun 1, 2023